Scilex Holding Co
SCLX14.530USD
+1.120+8.35%
交易中 （美东）报价延迟15分钟
79.82M总市值
亏损市盈率 TTM
关于 Scilex Holding Co 公司
Scilex Holding Company 专注于收购、开发和商业化用于治疗急性和慢性疼痛的非阿片类止痛药。该公司的商业产品 ZTlido（利多卡因外用系统）1.8% 是一种处方利多卡因外用产品，用于缓解带状疱疹后神经痛相关的疼痛，带状疱疹后神经痛是一种带状疱疹后神经痛。该公司还专注于商业化口服溶液 Gloperba（秋水仙碱 USP），这是一种预防成人痛风发作的药物。其第二个商业产品 ELYXYB 是一种潜在的一线治疗药物，是一种即用型口服溶液，用于成人偏头痛的急性治疗，无论有无先兆。其候选产品包括 SP-102（SEMDEXA）、SP-103 和 SP-104。SP-102 是一种粘稠凝胶制剂，是一种皮质类固醇，用于硬膜外注射治疗腰骶神经根痛或坐骨神经痛。其 SP-103 是 ZTlido 的三倍强度配方，用于治疗慢性颈部疼痛。
公司简介
公司代码SCLX
公司名称Scilex Holding Co
上市日期Jan 11, 2021
CEOMr. Jaisim Shah
员工数量115
证券类型Ordinary Share
年结日Jan 11
公司地址960 San Antonio Road
城市PALO ALTO
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编94303
电话16505164310
网址https://www.scilexholding.com/
公司代码SCLX
上市日期Jan 11, 2021
CEOMr. Jaisim Shah
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Henry H. Ji, Ph.D.
Dr. Henry H. Ji, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
19.45K
+3398.56%
Mr. Jaisim Shah
Mr. Jaisim Shah
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
8.43K
+3399.17%
Dr. Jay Chun, M.D., Ph.D.
Dr. Jay Chun, M.D., Ph.D.
Independent Director
Independent Director
3.21K
+3393.48%
Dr. Yue Alexander Wu, Ph.D.
Dr. Yue Alexander Wu, Ph.D.
Independent Director
Independent Director
714.00
+3470.00%
Mr. Dorman Followwill
Mr. Dorman Followwill
Independent Director
Independent Director
65.00
+3150.00%
Dr. Annu Navani, M.D.
Dr. Annu Navani, M.D.
Independent Director
Independent Director
--
--
Mr. Stephen Ma
Mr. Stephen Ma
Chief Financial Officer, Senior Vice President, Corporate Secretary
Chief Financial Officer, Senior Vice President, Corporate Secretary
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Henry H. Ji, Ph.D.
Dr. Henry H. Ji, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
19.45K
+3398.56%
Mr. Jaisim Shah
Mr. Jaisim Shah
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
8.43K
+3399.17%
Dr. Jay Chun, M.D., Ph.D.
Dr. Jay Chun, M.D., Ph.D.
Independent Director
Independent Director
3.21K
+3393.48%
Dr. Yue Alexander Wu, Ph.D.
Dr. Yue Alexander Wu, Ph.D.
Independent Director
Independent Director
714.00
+3470.00%
Mr. Dorman Followwill
Mr. Dorman Followwill
Independent Director
Independent Director
65.00
+3150.00%
Dr. Annu Navani, M.D.
Dr. Annu Navani, M.D.
Independent Director
Independent Director
--
--
收入明细
FY2024
FY2023
FY2022
FY2021
FY2020
暂无数据
地区USD
名称
营收
占比
United States
56.59M
0.00%
业务
地区
暂无数据
股东统计
更新时间: 7月2日 周三
更新时间: 7月2日 周三
持股股东
股东类型
持股股东
持股股东
占比
SCLX Stock Acquisition JV LLC
20.96%
Armistice Capital LLC
5.67%
State Street Global Advisors (US)
3.12%
The Vanguard Group, Inc.
2.42%
BlackRock Institutional Trust Company, N.A.
2.32%
Other
65.51%
持股股东
持股股东
占比
SCLX Stock Acquisition JV LLC
20.96%
Armistice Capital LLC
5.67%
State Street Global Advisors (US)
3.12%
The Vanguard Group, Inc.
2.42%
BlackRock Institutional Trust Company, N.A.
2.32%
Other
65.51%
股东类型
持股股东
占比
Corporation
21.11%
Hedge Fund
6.20%
Investment Advisor
5.95%
Investment Advisor/Hedge Fund
5.29%
Individual Investor
0.47%
Venture Capital
0.43%
Research Firm
0.37%
Sovereign Wealth Fund
0.20%
Pension Fund
0.09%
Other
59.90%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
242
2.85M
41.39%
-727.96K
2025Q1
252
1.46M
45.15%
-3.55M
2024Q4
251
112.59M
54.83%
-47.55M
2024Q3
250
97.43M
52.53%
-74.03M
2024Q2
251
103.17M
56.73%
-57.85M
2024Q1
249
91.86M
57.21%
-68.00M
2023Q4
233
89.70M
66.12%
-73.38M
2023Q3
225
92.65M
59.63%
-2.57M
2023Q2
215
84.74M
56.99%
-3.00M
2023Q1
187
79.37M
78.26%
-5.74M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
SCLX Stock Acquisition JV LLC
1.46M
20.98%
+1.42M
+3399.97%
May 01, 2025
Armistice Capital LLC
394.06K
5.67%
-116.72K
-22.85%
Mar 31, 2025
State Street Global Advisors (US)
216.87K
3.12%
+2.40K
+1.12%
Mar 31, 2025
The Vanguard Group, Inc.
168.51K
2.42%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
161.07K
2.32%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
46.00K
0.66%
+10.32K
+28.93%
Mar 31, 2025
RA Capital Management, LP
29.61K
0.43%
--
--
Mar 31, 2025
Northern Trust Investments, Inc.
22.63K
0.33%
+1.74K
+8.35%
Mar 31, 2025
BlackRock Financial Management, Inc.
21.34K
0.31%
--
--
Mar 31, 2025
UBS Financial Services, Inc.
20.53K
0.3%
+18.12K
+751.56%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Virtus LifeSci Biotech Clinical Trials ETF
0.03%
Direxion Daily S&P Biotech Bull 3X Shares
0.02%
Invesco NASDAQ Future Gen 200 ETF
0.01%
iShares Micro-Cap ETF
0.01%
Proshares Ultra Russell 2000
0%
Strive Small-Cap ETF
0%
Janus Henderson Small Cap Growth Alpha ETF
0%
DFA Dimensional US Core Equity Market ETF
0%
SPDR Portfolio MSCI Global Stock Market ETF
0%
Vanguard Total World Stock Index Fund
0%
查看更多
Virtus LifeSci Biotech Clinical Trials ETF
占比0.03%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.02%
Invesco NASDAQ Future Gen 200 ETF
占比0.01%
iShares Micro-Cap ETF
占比0.01%
Proshares Ultra Russell 2000
占比0%
Strive Small-Cap ETF
占比0%
Janus Henderson Small Cap Growth Alpha ETF
占比0%
DFA Dimensional US Core Equity Market ETF
占比0%
SPDR Portfolio MSCI Global Stock Market ETF
占比0%
Vanguard Total World Stock Index Fund
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
